The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective evaluation of pre-treatment ctDNA burden in localized osteosarcoma to identify patients with inferior outcomes: A report from the LEOPARD study.
 
David Stephen Shulman
Consulting or Advisory Role - Boehringer Ingelheim
 
Kelly S. Klega
No Relationships to Disclose
 
Nan Chen
No Relationships to Disclose
 
Elliot Gohn
No Relationships to Disclose
 
Donovan Henry
No Relationships to Disclose
 
Edwin Choy
Consulting or Advisory Role - Adaptimmune; Bayer; Daiichi Sankyo; Epizyme
Research Funding - Adaptimmune (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim; Exelixis (Inst); Genentech/Roche; Immune Design (Inst); Iterion Therapeutics (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst); TRACON Pharma (Inst)
 
Thomas Cash
Honoraria - EUSA Pharma
Consulting or Advisory Role - Y-mAbs Therapeutics
Research Funding - Celgene (Inst); Lilly (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - Lilly; United Therapeutics
 
Kris Ann Pinekenstein Schultz
No Relationships to Disclose
 
Leo Mascarenhas
Consulting or Advisory Role - Gilead Sciences; Novartis
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bayer (Inst); E.R. Squibb Sons, LLC (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Children's Oncology Group Foundation; The Pablove Foundation
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb/Celgene
 
Brian Turpin
No Relationships to Disclose
 
Bhuvana Setty
No Relationships to Disclose
 
Bradley DeNardo
No Relationships to Disclose
 
Douglas S. Hawkins
Research Funding - Bayer Health (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Pfizer (Inst)
 
Michael W. Bishop
Consulting or Advisory Role - Exelixis
Travel, Accommodations, Expenses - Exelixis
 
Avanthi T Shah
No Relationships to Disclose
 
Luke Devon Maese
Honoraria - Jazz Pharmaceuticals
Consulting or Advisory Role - Jazz Pharmaceuticals
Speakers' Bureau - Jazz Pharmaceuticals
 
Wendy B London
Consulting or Advisory Role - Healthcasts; Jubilant Radiopharma; Y-mAbs Therapeutics
Research Funding - Aileron Therapeutics; Bluebird Bio; Bristol-Myers Squibb; Novartis
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer; InhibRx; Jazz Pharmaceuticals
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Brian D. Crompton
Employment - Acceleron Pharma (I); Generate Biomedicines (I)
Leadership - New Age Industries (I)
Stock and Other Ownership Interests - Acceleron Pharma (I)
Consulting or Advisory Role - Animal Cancer Foundation; AstraZeneca; PetDx
Research Funding - Gradalis